Clinical Trials Browser

Phase 1/2 × Interventional × Advanced Pancreatic Cancer (Part 1) × Clear all

NCT06782685 2025-01-20

Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Phase 1/2 Recruiting

Gastrointestinal

Advanced Pancreatic Cancer (Part 1)